Revisão crítica do tratamento medicamentoso da gota no Brasil tratamento da hiperuricemia e da artrite gotosa e especialmente para. Download Citation on ResearchGate | On Jan 1, , D. Cruz Niesvaara and others published Revisión y actualización de la hiperuricemia }. Download Citation on ResearchGate | On Jan 1, , Maria do Rosário and others published Dieta e Medicamentos no Tratamento da Hiperuricemia em.

Author: Samulkree Maubei
Country: Japan
Language: English (Spanish)
Genre: Literature
Published (Last): 15 May 2007
Pages: 224
PDF File Size: 6.70 Mb
ePub File Size: 13.94 Mb
ISBN: 647-6-15115-836-4
Downloads: 76420
Price: Free* [*Free Regsitration Required]
Uploader: Doukasa

Portal Regional da BVS

Efeitos adversos no tratamento da tuberculose: Foram considerados como efeitos adversos maiores: Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. The dark side of antituberculosis therapy: Sociedade Brasileira de Pneumologia e Tisiologia.


I Consenso Brasileiro de Tuberculose. The adverse reactions of anti-tuberculosis drugs and its management. Rio de Janeiro RJ: Sociedade Brasileira de Pneumologia e Tisiologia; Adverse effects of antituberculosis drugs causing changes in treatment.

Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy. Toxic hepatitis with isoniazid and rifampin. A Hepatotoxicidade das Drogas Antituberculosas. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, tratmaento regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide.

Results at 30 months. Am Rev Respir Dis. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong.

Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Denise Eri Onodera Vieira Av.


All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Services on Demand Journal. SCS Quadra 1, Bl. How to cite this article.